Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 04/29 05:44:42 pm
111.565 USD   -0.81%
04/28DJJOHNSON & JOHNS : Raises Dividend by 6.7%
04/28 JOHNSON & JOHNS : hikes dividend at shareholders meeting
04/28 JOHNSON & JOHNS : Announces Dividend Increase of 6.7%
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/22/2012 | 12:13am CEST
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on JOHNSON & JOHNSON
04/28 JOHNSON & JOHNSON : Flex Appoints John Carlson as President of Flex Medical Solu..
04/28 JOHNSON & JOHNSON : Reports Summarize Biogenic Amines Study Results from Janssen..
04/28DJJOHNSON & JOHNSON : Raises Dividend by 6.7%
04/28 JOHNSON & JOHNSON : hikes dividend at shareholders meeting
04/28 JOHNSON & JOHNSON : Announces Dividend Increase of 6.7%
04/28DJCARDINAL HEALTH : Revenue Climbs, Driven by Pharmaceuticals Segment
04/27DJCURRENCY TRADING : Weak Dollar Gives Boost to U.S. Earnings -- WSJ
04/27 Clampdown on trade secret theft seen passing U.S. Congress
04/27 With Exxon credit reduced a notch, Microsoft is one of two at top rating
04/26DJWeak Dollar Gives a Lift to U.S. Earnings
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials